Project Details
Description
EuroGCT has two major objectives:
• To provide patients, people affected by conditions, healthcare professionals and citizens with accurate scientific, legal, ethical and societal information and with engagement opportunities, and thus to support better informed decisionmaking related to cell and gene-based therapies.
• To facilitate better decision-making at key points in development of new therapies and thus enable improved product development, by providing the research community and regulatory
• To provide patients, people affected by conditions, healthcare professionals and citizens with accurate scientific, legal, ethical and societal information and with engagement opportunities, and thus to support better informed decisionmaking related to cell and gene-based therapies.
• To facilitate better decision-making at key points in development of new therapies and thus enable improved product development, by providing the research community and regulatory
Funding Acknowledgement(s)
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 965241
-
-
| Short title or EU acronym | EuroGCT |
|---|---|
| Acronym | EUAR58 |
| Status | Active |
| Effective start/end date | 1/02/21 → 31/01/26 |
Funding
- European Commission
Keywords
- information
- communication
- engagement
- cell therapy
- gene therapy
- genome editing
- stem cells
- research
- clinical trials
- regulation
- ethics
- patients
- industry
- manufacturing
- IPR
Flemish discipline codes in use since 2023
- Cellular therapy
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.